Thornhill, Canada

Rangachari Narashimhan


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rangachari Narashimhan: Innovator in Antifungal Treatments

Introduction

Rangachari Narashimhan is a notable inventor based in Thornhill, CA. He has made significant contributions to the field of medicine, particularly in the formulation of antifungal agents. His work focuses on innovative methods for pulmonary administration, which can greatly enhance treatment options for patients suffering from fungal infections.

Latest Patents

Narashimhan holds a patent for a formulation designed for the pulmonary administration of antifungal agents. This patent includes methods of manufacture and use, specifically targeting the treatment of pulmonary aspergillosis with amphotericin B-containing formulations. The formulations aim to provide effective treatment options for patients, showcasing Narashimhan's commitment to advancing medical science.

Career Highlights

Throughout his career, Narashimhan has been associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, further enhancing the impact of his innovations. His dedication to research and development has positioned him as a key figure in the fight against fungal infections.

Collaborations

Narashimhan has worked alongside esteemed colleagues such as Thomas E. Tarara and Jeffry G. Weers. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of his patented formulations.

Conclusion

Rangachari Narashimhan's contributions to antifungal treatments through his innovative formulations and methods highlight his importance in the medical field. His work continues to pave the way for improved patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…